Aspirin/therapeutic use; Platelet Aggregation Inhibitors/therapeutic use; Pre-Eclampsia/prevention & control; Aspirin/pharmacology; Cost-Benefit Analysis; Female; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors/pharmacology; Pre-Eclampsia/economics; Pregnancy; Pregnancy Complications/prevention & control; Pregnancy, Multiple; Randomized Controlled Trials as Topic

Aspirin for Evidence-Based Preeclampsia Prevention; Fetal Medicine Foundation; abruption; adverse pregnancy outcome; algorithm; aspirin; blood pressure; competing risk; fetal growth restriction; first trimester; hypertension; intrauterine growth restriction; mean arterial pressure; morbidity; mortality; number needed to screen; number needed to treat; perinatal; placental growth factor; placental insufficiency; prediction; preeclampsia; pregnancy; pregnancy complications; prematurity; preterm; prevention; prophylaxis; pulsatility index; resistant index; risk factor; safety; stillbirth; uterine artery; uterine artery mean pulsatility index